Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Hartl

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Journal of Medicinal Chemistry|November 26, 1993
Nonprostanoid prostacyclin mimetics. 4. Derivatives of 2-[3-[2-(4,5-diphenyl-2-oxazolyl)ethyl]phenoxy]acetic acid substituted alpha to the oxazole ringN A Meanwell, M J Rosenfeld, J J Wright, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1992
Pharmacological characterization of potent, long-acting thromboxane receptor antagonists, SQ 33,261 and SQ 33,552D N Harris, I M Michel, H J Goldenberg, et al.
Bioorganic & Medicinal Chemistry Letters|April 15, 2004
Solid-phase synthesis and SAR of 4-carboxy-2-azetidinone mechanism-based tryptase inhibitorsJames C Sutton, Scott A Bolton, Malcolm E Davis, et al.
Bioorganic & Medicinal Chemistry Letters|April 15, 2004
Synthesis of potent and highly selective nonguanidine azetidinone inhibitors of human tryptaseGregory S Bisacchi, William A Slusarchyk, Scott A Bolton, et al.
Pneumologie (Stuttgart, Germany)|March 10, 2018
[Guideline for the Diagnosis and Treatment of COPD Patients - Issued by the German Respiratory Society and the German Atemwegsliga in Cooperation with the Austrian Society of Pneumology]C Vogelmeier, R Buhl, O Burghuber, et al.
Journal of Molecular and Cellular Cardiology|June 14, 2023
Ythdf2 regulates cardiac remodeling through its mRNA target transcriptsV Kmietczyk, J Oelschläger, P Gupta, et al.
Bioorganic & Medicinal Chemistry Letters|October 10, 2002
Synthesis and SAR of 4-carboxy-2-azetidinone mechanism-based tryptase inhibitorsJames C Sutton, Scott A Bolton, Karen S Hartl, et al.
Bioorganic & Medicinal Chemistry Letters|October 10, 2002
Synthesis of potent and highly selective inhibitors of human tryptaseWilliam A Slusarchyk, Scott A Bolton, Karen S Hartl, et al.
Journal of Medicinal Chemistry|November 13, 2008
Design, structure-activity relationships, X-ray crystal structure, and energetic contributions of a critical P1 pharmacophore: 3-chloroindole-7-yl-based factor Xa inhibitorsYan Shi, Doree Sitkoff, Jing Zhang, et al.
Bioorganic & Medicinal Chemistry Letters|June 23, 2009
Cyanoguanidine-based lactam derivatives as a novel class of orally bioavailable factor Xa inhibitorsYan Shi, Jing Zhang, Mengxiao Shi, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Journal of Medicinal Chemistry|November 26, 1993
Nonprostanoid prostacyclin mimetics. 4. Derivatives of 2-[3-[2-(4,5-diphenyl-2-oxazolyl)ethyl]phenoxy]acetic acid substituted alpha to the oxazole ringN A Meanwell, M J Rosenfeld, J J Wright, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1992
Pharmacological characterization of potent, long-acting thromboxane receptor antagonists, SQ 33,261 and SQ 33,552D N Harris, I M Michel, H J Goldenberg, et al.
Bioorganic & Medicinal Chemistry Letters|April 15, 2004
Solid-phase synthesis and SAR of 4-carboxy-2-azetidinone mechanism-based tryptase inhibitorsJames C Sutton, Scott A Bolton, Malcolm E Davis, et al.
Bioorganic & Medicinal Chemistry Letters|April 15, 2004
Synthesis of potent and highly selective nonguanidine azetidinone inhibitors of human tryptaseGregory S Bisacchi, William A Slusarchyk, Scott A Bolton, et al.
Pneumologie (Stuttgart, Germany)|March 10, 2018
[Guideline for the Diagnosis and Treatment of COPD Patients - Issued by the German Respiratory Society and the German Atemwegsliga in Cooperation with the Austrian Society of Pneumology]C Vogelmeier, R Buhl, O Burghuber, et al.
Journal of Molecular and Cellular Cardiology|June 14, 2023
Ythdf2 regulates cardiac remodeling through its mRNA target transcriptsV Kmietczyk, J Oelschläger, P Gupta, et al.
Bioorganic & Medicinal Chemistry Letters|October 10, 2002
Synthesis and SAR of 4-carboxy-2-azetidinone mechanism-based tryptase inhibitorsJames C Sutton, Scott A Bolton, Karen S Hartl, et al.
Bioorganic & Medicinal Chemistry Letters|October 10, 2002
Synthesis of potent and highly selective inhibitors of human tryptaseWilliam A Slusarchyk, Scott A Bolton, Karen S Hartl, et al.
Journal of Medicinal Chemistry|November 13, 2008
Design, structure-activity relationships, X-ray crystal structure, and energetic contributions of a critical P1 pharmacophore: 3-chloroindole-7-yl-based factor Xa inhibitorsYan Shi, Doree Sitkoff, Jing Zhang, et al.
Bioorganic & Medicinal Chemistry Letters|June 23, 2009
Cyanoguanidine-based lactam derivatives as a novel class of orally bioavailable factor Xa inhibitorsYan Shi, Jing Zhang, Mengxiao Shi, et al.
Pageof 4